Law360, New York (April 18, 2014, 4:35 PM EDT) -- Axinn Veltrop & Harkrider LLP's Chad Landmon recently helped Actavis Inc. strike a settlement deal with Shire LLC allowing Actavis to market a generic version of the lucrative drug Intuniv and previously secured a courtroom win over the U.S. Food and Drug Administration for Watson Laboratories Inc., landing himself among Law360's top intellectual property attorneys under 40.
Landmon, 39, currently serves as the head of Axinn Veltrop's intellectual property and FDA practice groups, and it's his IP litigation and counseling skills combined with his uniquely comprehensive knowledge of the FDA that sets him apart from his peers and makes him sought after by...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!